开始
matt.sulli42

bullish on REGN

做多
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)  
matt.sulli42  
NASDAQ:REGN   Regeneron Pharmaceuticals, Inc.
biotechnology biotech REGN
1
0
biotechnology biotech regn
REGN could head north of 400 post earnings, time to get in is between now @ 358.50 and a low of around 320

相关观点

matt.sulli42
Regeneron: Will wave V be enough to break resistance?
matt.sulli42
Short WLL
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。